The yin and yang of interleukin-2-mediated immunotherapy

N Engl J Med. 2011 Dec 1;365(22):2129-31. doi: 10.1056/NEJMe1110900.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Female
  • Graft vs Host Disease / drug therapy*
  • Hepatitis C, Chronic / complications*
  • Humans
  • Interleukin-2 / administration & dosage*
  • Interleukin-2 / therapeutic use*
  • Male
  • T-Lymphocytes, Regulatory / immunology*
  • Vasculitis / drug therapy*

Substances

  • Interleukin-2